Clinicians' attitudes towards management of metastatic colorectal adenocarcinoma

ANZ Journal of Surgery

Volumn 78, Issue 6, 2008, Pages 454-460

  Wong, Rachel ^a   Wiley, Malcolm ^a   Christophi, Christopher ^a   Tebbutt, Niall ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

Attitude; Colorectal adenocarcinoma; Synchronous metastasis

Indexed keywords

ARTICLE; AUSTRALIA; CANCER CHEMOTHERAPY; CANCER SURGERY; CECUM TUMOR; CLINICAL PRACTICE; COLORECTAL ADENOCARCINOMA; COLORECTAL CARCINOMA; FEASIBILITY STUDY; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; METASTASIS; PHYSICIAN ATTITUDE; QUESTIONNAIRE; SIGMOID; SURGEON;

ADENOCARCINOMA; ADULT; ATTITUDE OF HEALTH PERSONNEL; CLINICAL COMPETENCE; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; HEALTH CARE SURVEYS; HUMANS; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PROFESSIONAL PRACTICE;

EID: 44649163396     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2008.04534.x     Document Type: Article

References (13)

1. Tebbutt NC, Norman AR, Cunningham D et al. Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut 2003 52 : 568 73.
2. Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW. Colorectal cancer. Lancet 2005 365 : 153 65.
3. Nordlinger B, Benoist S. Benefits and risks of neoadjuvant therapy for liver metastases. J. Clin. Oncol. 2006 24 : 4954 5.
4. Hurwitz H, Fehrenbacher L, Novotny W et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N. Engl. J. Med. 2004 350 : 2335 42.
5. Grothey A, Sargent D, Goldberg RM, Schmoll HJ. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J. Clin. Oncol. 2004 22 : 1209 14.
6. Cunningham D, Humblet Y, Siena S et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N. Engl. J. Med. 2004 351 : 337 45.
7. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. Nordic Gastrointestinal Tumor Adjuvant Therapy Group. J. Clin. Oncol. 1992 10 : 904 11.
8. Sarela AI, Guthrie JA, Seymour MT, Ride E, Guillou PJ, O'Riordain DS. Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer. Br. J. Surg. 2001 88 : 1352 6.
9. Scoggins CR, Meszoely IM, Blanke CD, Beauchamp RD, Leach SD. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann. Surg. Oncol. 1999 6 : 651 7.
10. Sarela A, O'Riordain DS. Rectal adenocarcinoma with liver metastases: management of the primary tumour. Br. J. Surg. 2001 88 : 163 4.
11. Crane CH, Janjan NA, Abbruzzese JL et al. Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 2001 49 : 107 16.
12. Mahteme H, Pahlman L, Glimelius B, Graf W. Prognosis after surgery in patients with incurable rectal cancer: a population-based study. Br. J. Surg. 1996 83 : 1116 20.
13. Borowski DW, Kelly SB, Bradburn DM, Wilson RG, Gunn A, Ratcliffe AA. Impact of surgeon volume and specialization on short-term outcomes in colorectal cancer surgery. Br. J. Surg. 2007 94 : 880 89.